Effects of Pharmaceutical Care Based on the Clinical Practice Guideline of Migraine in a University Pharmacy: a Pilot Study
Article Sidebar
Main Article Content
Abstract
Objective: To compare treatment outcomes between patients with migraine receiving pharmaceutical care based on clinical practice guideline of migraine and those receiving usual medical treatment from pharmacy. Methods: A randomized controlled trial was carried out between January 1 and March 31, 2011. A total of 46 patients were randomly allocated into 2 groups, i.e., those receiving pharmaceutical care based on the clinical practice guideline of migraine (a treatment group, n=23) and those receiving usual medical treatment from a pharmacy (control group, n=23). The researchers measured severity of headache pain, frequency of headache attacks and health status and overall happiness for two months. Results: The treatment group and the control showed no difference in severity of headache pain and frequency of headache attacks at day 1, week 4 and 8 (p>0.05). However, social and spiritual health, and overall happiness at week 4 and 8 in the treatment group were significantly higher than those in the control group (p<0.05). Moreover, mental health in the treatment group was higher than that in the control group (p<0.05). Conclusion: Pharmaceutical care based on a clinical practice guideline of migraine does not improve headache pain and frequency of headache attack including physical health in patients with migraine when compared with a usual medical treatment of a pharmacy. However, it improves social, spiritual, and mental health including overall happiness in patients with migraine
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Phanthumchinda K, Kamol-Ratanakul P. Prevalence of primary headache in central region of Thailand: a cross-sectional survey. J Neurol. 1999;246 (suppl 1):P319.
3. Phanthumchinda K, Sithi-Amorn C. Prevalence and clinical features of migraine: a community survey in Bangkok, Thailand. Headache. 1989; 29 : 594-7.
4. van Mil JF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harvard Health Policy Rev. 2006; 7: 155-68.
5. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003; 25: 218-26.
6. Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001; 18: 63-77.
7. Petkova VB. Pharmaceutical care for asthma patients: a community pharmacy-based pilot project. Allergy Asthma Proc. 2008; 29: 55-61.
8. Mangiapane S, Schulz M, Muhlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother. 2005; 39: 1817-22.
9. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997; 31: 713-9.
10. Paulos CP, Nygren CE, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother. 2005;39:939-43.
11. Hoffmann W, Herzog B, Muhlig S, Kayser H, Fabian R, Thomsen M, et al. Pharmaceutical care for migraine and headache patients: a community-based randomized intervention. Ann Pharmacother 2008;42:1804-13.
12. OTC Products: A study of pharmacists' recom- mendations. Pharm Times. 2001:10-30.
13. Kamnuansilpa P. Migraine dispensing manage- ment by community pharmacies in Chaingyuen and Kantharawichai districts, Mahasarakham [master thesis]. Maha Sarakham: Mahasarakham University; 2010.
14. Saengcharoen W, Lerkiatbundit S. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand. Headache. 2013;53:1451-63.
15. Pannachet T. Common Headaches. In: Chaisuk- sant S, Chiewthanakul P, Nutstaporn T, editors. Ambulatory Medicine. Khon Kane: Medicine department, Konkaen Hospital; 2014. p. 3-9.
16. Beithon J, Gallenberg M, Johnson K, Kildahl P, Krenik J, Liebow M, et al. Diagnosis and treatment of headache [online]: Institute for Clinical Systems Improvement; 2013 [cited Mar 10, 2016]. Available from: www.icsi.org/asset/qwrznq/Headache.pdf.
17. The International Headache Society. The International Classification of Headache Disorders, 2nd Edition (ICHD-II). Cephalalgia. 2004;24:1-147.
18. Saengcharoen W, Buasri N, Khantapokha B, Lerkiatbundit S. Public knowledge and factors associated with inappropriate analgesic use: a survey in Thailand. Int J Pharm Pract. 2016;24:22-9.
19. Parakho P. A feasibility of Yoga and self control intervention on headache and quality of sleep among migraine patients at Mahasarakham hospital [master thesis]. Khon Kaen: Khon Kaen University; 2009.
20. Hassinger HJ, Semenchuk EM, O'Brien WH. Appraisal and coping responses to pain and stress in migraine headache sufferers. J Behav Med. 1999:327.
21. Chow S-C. Sample size calculations for clinical trials. Wiley Interdiscip Rev Comput Stat. 2011; 3:414-27.
22. Lipsey MW, Wilson DB. The efficacy of psychological, educational, and behavioral treatment.confirmation from meta-analysis. Am Psychol. 1993;48:1181-209.
23. Hohern E. Effects of educational documents in migraine dispensing management by community pharmacies in outside districts of Maha Sarakham [master thesis]. Maha Sarakham: Mahasarkham University; 2010.
24. Ploylearmsang C. Effectiveness of integration of health promotion and prevention in the pharmacy curriculum. Mahasarakham: Mahasarakham University; 2009.
25. Michel P, Dartigues JF, Henry P, Tison S, Auriacombe S, Brochet B, et al. Validity of the International Headache Society criteria for migraine. GRIM. Groupe de Recherche Interdisci- plinaire sur la Migraine. Neuroepidemiology. 1993; 12:51-7.
26. Lanteri-Minet M, Nachit-Ouinekh F, Mihout B, Slama A, El Hasnaoui A. The treatment of migraine by pharmacists: a French multicenter study. Rev Neurol. 2004;160:441-6.
27. Wenzel RG, Lipton RB, Diamond ML, Cady R. Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns. Headache. 2005;45:47-52.
